| Application no. and date | 11184022.9 (espacenet) (Federated) (European Patent Register), 20070126 | | Patent/reg. no. and date | DK/EP 2478916, 20200401 | | Publication date | 20120725 | | Priority no. and date | GB 0601733, 20060127, GB 0620175, 20061011 | | EP pub. no. and date |
EP 2478916 20120725 | | Effective date | | | Applicant/owner | Seqirus UK Limited, Point
Level 3, 29 Market Street
Maidenhead, Berkshire SL6 8AA, GB | | Applicant ref. no. | P73363DK01 | | Inventor | Broeker, Michael, Novartis Vaccines and Diagnostics GmbH
Emil-von-Behring-Strasse 76
35041 Marburg, DE,
Kost, Holger, Novartis Vaccines and Diagnostics GmbH
Emil-von-Behring-Strasse 76
35041 Marburg, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/145 (2006.01) | | Title | Influenzavacciner indeholdende hæmagglutinin og matrixproteiner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
